Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Stomatocytosis and xerocytosis

Carlo Brugnara, MD
Section Editor
Donald H Mahoney, Jr, MD
Deputy Editor
Jennifer S Tirnauer, MD


Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX) are rare disorders that present with various degrees of hemolytic anemia and abnormal red blood cell (RBC) morphologies. Both types of disorders are characterized by alterations in RBC hydration. Occasionally, stomatocytes or xerocytes are seen in other inherited or acquired conditions.

This topic discusses the mechanisms, evaluation, and management of stomatocytosis and xerocytosis.

Our approaches to the patient with hemolytic anemia and other RBC morphologic abnormalities are discussed separately:

Anemia (child) – (See "Approach to the child with anemia".)

Anemia (adult) – (See "Approach to the adult patient with anemia".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2017. | This topic last updated: Aug 18, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Clark MR, Shohet SB, Gottfried EL. Hereditary hemolytic disease with increased red blood cell phosphatidylcholine and dehydration: one, two, or many disorders? Am J Hematol 1993; 42:25.
  2. Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A 1974; 71:4457.
  3. Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim Biophys Acta 1968; 163:494.
  4. King MJ, Garçon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 2015; 37:304.
  5. Kanzaki A, Yawata Y. Hereditary stomatocytosis: phenotypical expression of sodium transport and band 7 peptides in 44 cases. Br J Haematol 1992; 82:133.
  6. Gallagher PG, Forget BG, Lux SE. Disorders of the erythrocyte membrane. In: Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look TA (Eds), WB Saunders, Philadelphia 2003. p.560.
  7. Rinehart J, Gulcicek EE, Joiner CH, et al. Determinants of erythrocyte hydration. Curr Opin Hematol 2010; 17:191.
  8. Vives Corrons JL, Besson I, Aymerich M, et al. Hereditary xerocytosis: a report of six unrelated Spanish families with leaky red cell syndrome and increased heat stability of the erythrocyte membrane. Br J Haematol 1995; 90:817.
  9. Paterakis GS, Laoutaris NP, Alexia SV, et al. The effect of red cell shape on the measurement of red cell volume. A proposed method for the comparative assessment of this effect among various haematology analysers. Clin Lab Haematol 1994; 16:235.
  10. Shojania AM, Godin DV, Frohlich J. Hereditary high phosphatidylcholine hemolytic anemia: report of a new family and review of the literature. Clin Invest Med 1990; 13:313.
  11. Yoshimoto A, Fujimura M, Nakao S. Pulmonary hypertension after splenectomy in hereditary stomatocytosis. Am J Med Sci 2005; 330:195.
  12. Vicente-Gutiérrez MP, Castelló-Almazán I, Salvía-Roiges MD, et al. Nonimmune hydrops fetalis due to congenital xerocytosis. J Perinatol 2005; 25:63.
  13. Ogburn PL Jr, Ramin KD, Danilenko-Dixon D, et al. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis. Am J Obstet Gynecol 2001; 185:238.
  14. Platt OS, Lux SE, Nathan DG. Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity. J Clin Invest 1981; 68:631.
  15. Archer NM, Shmukler BE, Andolfo I, et al. Hereditary xerocytosis revisited. Am J Hematol 2014; 89:1142.
  16. Clark MR, Mohandas N, Caggiano V, Shohet SB. Effects of abnormal cation transport on deformability of desiccytes. J Supramol Struct 1978; 8:521.
  17. Wiley JS, Cooper RA, Adachi K, Asakura T. Hereditary stomatocytosis: association of low 2,3-diphosphoglycerate with increased cation pumping by the red cell. Br J Haematol 1979; 41:133.
  18. Darghouth D, Koehl B, Heilier JF, et al. Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis. Haematologica 2011; 96:1861.
  19. Rapetti-Mauss R, Lacoste C, Picard V, et al. A mutation in the Gardos channel is associated with hereditary xerocytosis. Blood 2015; 126:1273.
  20. Smith BD, Segel GB. Abnormal erythrocyte endothelial adherence in hereditary stomatocytosis. Blood 1997; 89:3451.
  21. Stewart GW. The membrane defect in hereditary stomatocytosis. Baillieres Clin Haematol 1993; 6:371.
  22. Eber SW, Lande WM, Iarocci TA, et al. Hereditary stomatocytosis: consistent association with an integral membrane protein deficiency. Br J Haematol 1989; 72:452.
  23. Fricke B, Argent AC, Chetty MC, et al. The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. Blood 2003; 102:2268.
  24. Lande WM, Thiemann PV, Mentzer WC Jr. Missing band 7 membrane protein in two patients with high Na, low K erythrocytes. J Clin Invest 1982; 70:1273.
  25. Bae C, Gnanasambandam R, Nicolai C, et al. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci U S A 2013; 110:E1162.
  26. Zarychanski R, Schulz VP, Houston BL, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood 2012; 120:1908.
  27. Jaffé ER, Gottfried EL. Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes. J Clin Invest 1968; 47:1375.
  28. Wiley JS, Ellory JC, Shuman MA, et al. Characteristics of the membrane defect in the hereditary stomatocytosis syndrome. Blood 1975; 46:337.
  29. Shohet SB, Nathan DG, Livermore BM, et al. Hereditary hemolytic anemia associated with abnormal membrane lipid. II. Ion permeability and transport abnormalities. Blood 1973; 42:1.
  30. Flatt JF, Bruce LJ. The hereditary stomatocytoses. Haematologica 2009; 94:1039.
  31. Andolfo I, Alper SL, De Franceschi L, et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 2013; 121:3925.
  32. Albuisson J, Murthy SE, Bandell M, et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun 2013; 4:1884.
  33. Glogowska E, Schneider ER, Maksimova Y, et al. Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis. Blood 2017.
  34. Layton DM, Bain BJ. Dehydrated hereditary stomatocytosis. Am J Hematol 2016; 91:266.
  35. Fermo E, Vercellati C, Marcello AP, et al. Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families. Case Rep Hematol 2017; 2017:2769570.
  36. Yang E, Voelkel EB, Lezon-Geyda K, et al. Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis. Pediatr Blood Cancer 2017; 64.
  37. GARDOS G. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 1958; 30:653.
  38. Glogowska E, Lezon-Geyda K, Maksimova Y, et al. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis. Blood 2015; 126:1281.
  39. Andolfo I, Russo R, Manna F, et al. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis). Am J Hematol 2015; 90:921.
  40. Fermo E, Bogdanova A, Petkova-Kirova P, et al. 'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation. Sci Rep 2017; 7:1744.
  41. Rapetti-Mauss R, Soriani O, Vinti H, et al. Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel. Haematologica 2016; 101:e431.
  42. Rivera A, Vandorpe DH, Shmukler BE, et al. Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc. Am J Hematol 2017; 92:E108.
  43. Bruce LJ, Guizouarn H, Burton NM, et al. The monovalent cation leak in overhydrated stomatocytic red blood cells results from amino acid substitutions in the Rh-associated glycoprotein. Blood 2009; 113:1350.
  44. Goossens D, Trinh-Trang-Tan MM, Debbia M, et al. Generation and characterisation of Rhd and Rhag null mice. Br J Haematol 2010; 148:161.
  45. Stewart AK, Shmukler BE, Vandorpe DH, et al. Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol 2011; 301:C1325.
  46. Iolascon A, De Falco L, Borgese F, et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica 2009; 94:1049.
  47. Guizouarn H, Martial S, Gabillat N, Borgese F. Point mutations involved in red cell stomatocytosis convert the electroneutral anion exchanger 1 to a nonselective cation conductance. Blood 2007; 110:2158.
  48. Stewart AK, Kedar PS, Shmukler BE, et al. Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. Am J Physiol Cell Physiol 2011; 300:C1034.
  49. Bruce LJ, Robinson HC, Guizouarn H, et al. Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat Genet 2005; 37:1258.
  50. Stewart GW, Amess JA, Eber SW, et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 1996; 93:303.
  51. Andolfo I, Alper SL, Delaunay J, et al. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia. Am J Hematol 2013; 88:66.
  52. Andolfo I, Russo R, Manna F, et al. Functional characterization of novel ABCB6 mutations and their clinical implications in familial pseudohyperkalemia. Haematologica 2016; 101:909.
  53. Bawazir WM, Gevers EF, Flatt JF, et al. An infant with pseudohyperkalemia, hemolysis, and seizures: cation-leaky GLUT1-deficiency syndrome due to a SLC2A1 mutation. J Clin Endocrinol Metab 2012; 97:E987.
  54. Rees DC, Iolascon A, Carella M, et al. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 2005; 130:297.
  55. Kaya Z, Niu DM, Yorulmaz A, et al. A novel mutation of ABCG5 gene in a Turkish boy with phytosterolemia presenting with macrotrombocytopenia and stomatocytosis. Pediatr Blood Cancer 2014; 61:1457.
  56. Wang G, Cao L, Wang Z, et al. Macrothrombocytopenia/stomatocytosis specially associated with phytosterolemia. Clin Appl Thromb Hemost 2012; 18:582.
  57. Entezami M, Becker R, Menssen HD, et al. Xerocytosis with concomitant intrauterine ascites: first description and therapeutic approach. Blood 1996; 87:5392.
  58. Grootenboer-Mignot S, Crétien A, Laurendeau I, et al. Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenat Diagn 2003; 23:380.
  59. Grootenboer S, Schischmanoff PO, Laurendeau I, et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood 2000; 96:2599.
  60. Wiley JS. Inherited red cell dehydration: a hemolytic syndrome in search of a name. Pathology 1984; 16:115.
  61. Stewart GW, Corrall RJ, Fyffe JA, et al. Familial pseudohyperkalaemia. A new syndrome. Lancet 1979; 2:175.
  62. Alani FS, Dyer T, Hindle E, et al. Pseudohyperkalaemia associated with hereditary spherocytosis in four members of a family. Postgrad Med J 1994; 70:749.
  63. Fricke B, Jarvis HG, Reid CD, et al. Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction. Br J Haematol 2004; 125:796.
  64. Gallagher PG, Lux SE. Disorders of the erythrocyte membrane. In: Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look TA (Eds), WB Saunders, Philadelphia 2003. p.560.
  65. LOCK SP, SMITH RS, HARDISTY RM. Stomatocytosis: a hereditary red cell anomally associated with haemolytic anaemia. Br J Haematol 1961; 7:303.
  66. Jarvis HG, Gore DM, Briggs C, et al. Cold storage of 'cryohydrocytosis' red cells: the osmotic susceptibility of the cold-stored erythrocyte. Br J Haematol 2003; 122:859.
  67. El Nabouch M, Rakotoharinandrasana I, Ndayikeza A, et al. Infantile pyknocytosis, a rare cause of hemolytic anemia in newborns: report of two cases in twin girls and literature overview. Clin Case Rep 2015; 3:535.
  68. Coutinho M, Costa E, Monteiro T, et al. Infantile pyknocytosis: an under-recognized form of neonatal hemolytic anemia? Lab Hematol 2012; 18:27.
  69. Eyssette-Guerreau S, Bader-Meunier B, Garcon L, et al. Infantile pyknocytosis: a cause of haemolytic anaemia of the newborn. Br J Haematol 2006; 133:439.
  70. Davidson RJ, How J, Lessels S. Acquired stomatocytosis: its prevalence of significance in routine haematology. Scand J Haematol 1977; 19:47.
  71. Ballas SK, Clark MR, Mohandas N, et al. Red cell membrane and cation deficiency in Rh null syndrome. Blood 1984; 63:1046.
  72. Remaley AT, Schumacher UK, Stonik JA, et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997; 17:1813.
  73. Reinhart WH, Gössi U, Bütikofer P, et al. Haemolytic anaemia in analpha-lipoproteinaemia (Tangier disease): morphological, biochemical, and biophysical properties of the red blood cell. Br J Haematol 1989; 72:272.
  74. Neff AT. Sitosterolemia's stomatocytosis and macrothrombocytopenia. Blood 2012; 120:4283.
  75. Wang Z, Cao L, Su Y, et al. Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia. Am J Hematol 2014; 89:320.
  76. Goodyer M, Lovey J, Menétrey MJ. Peripheral blood features of phytosterolaemia. Br J Haematol 2015; 171:669.
  77. Wislöff F, Boman D. Acquired stomatocytosis in alcoholic liver disease. Scand J Haematol 1979; 23:43.
  78. Douglass CC, Twomey JJ. Transient stomatocytosis with hemolysis: a previously unrecognized complication of alcoholism. Ann Intern Med 1970; 72:159.
  79. Ohsaka A, Kano Y, Sakamoto S, et al. A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration. Nihon Ketsueki Gakkai Zasshi 1989; 52:7.
  80. Schrier SL, Zachowski A, Devaux PF. Mechanisms of amphipath-induced stomatocytosis in human erythrocytes. Blood 1992; 79:782.
  81. Clark MR, Morrison CE, Shohet SB. Monovalent cation transport in irreversibly sickled cells. J Clin Invest 1978; 62:329.
  82. Bertles JF, Milner PF. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. J Clin Invest 1968; 47:1731.
  83. Kaul DK, Chen D, Zhan J. Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 1994; 83:3006.
  84. Kaul DK, Fabry ME, Nagel RL. Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood 1986; 68:1162.
  85. Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992; 79:2154.
  86. Lawrence C, Fabry ME, Nagel RL. Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia. J Lab Clin Med 1985; 105:706.
  87. Gibson JS, Speake PF, Ellory JC. Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells. J Physiol 1998; 511 ( Pt 1):225.
  88. Brugnara C, de Franceschi L, Alper SL. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993; 92:520.
  89. Olivieri O, Vitoux D, Galacteros F, et al. Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood 1992; 79:793.
  90. Ataga KI, Reid M, Ballas SK, et al. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol 2011; 153:92.
  91. Brugnara C, Kopin AS, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75:1608.
  92. Brugnara C. Characteristics of the volume- and chloride-dependent K transport in human erythrocytes homozygous for hemoglobin C. J Membr Biol 1989; 111:69.
  93. Fabry ME, Romero JR, Suzuka SM, et al. Hemoglobin C in transgenic mice with full mouse globin knockouts [abstract]. Blood 1998; 92:330a.
  94. Romero JR, Suzuka SM, Nagel RL, Fabry ME. Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells. Blood 2004; 103:2384.